RAMYRO

MammoSight™

AI powered Mammography Breast Cancer Screening Solution

Overview

Mammography is the gold standard imaging technique for early detection of breast cancer, capable of identifying tumors and micro-calcification before they become clinically palpable. Early diagnosis significantly improves treatment outcomes and survival rates. However, interpretation can be challenging due to subtle findings, breast density variations, and human fatigue.

MammoSight™ is an advanced AI-powered mammography solution designed to significantly reduce false negative rates, using a unique and highly optimized approach to achieve near-zero false negatives. It streamlines the breast cancer screening process by quickly filtering out healthy patients, enabling radiologists to focus on cases that require attention, all with unmatched accuracy.

RAMYRO Breast Cancer Mammography AI software

Key Features

RAMYRO Mammography AI universal viewer
  • Achieves near-zero false negative rates by employing a finely tuned AI algorithm that ensures high precision in cancer detection.
  • Detect suspicious masses, architectural distortions, and calcifications with high sensitivity and flag high-risk cases for priority review.
  • Automatically assign preliminary BI-RADS categories based on lesion characteristics.
  • Streamlines the screening process by efficiently filtering out healthy patients, allowing radiologists to focus on cases that need immediate attention.
  • Automatically prioritizes patients based on detected abnormalities and clinical risk factors, using an advanced risk-ranking system.
  • Generates preliminary reports automatically, helping radiologists save time and improving diagnostic confidence.
  • Offers full transparency through explainable AI, ensuring clinicians can understand and trust the results provided by the system.

Key Benefits

  • Integrating ramyro Breast Cancer AI module into mammography workflows accelerates reading time, enhances detection rates especially in dense breast tissue and aids in triaging cases for timely intervention.
  • This synergy of human expertise and AI-powered analysis strengthens breast cancer screening programs and ultimately saves lives.